Attitudes among parents of persons with autism spectrum disorder towards information about genetic risk and future health.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
10 2022
Historique:
received: 07 03 2021
accepted: 13 09 2021
revised: 01 09 2021
pubmed: 16 11 2021
medline: 14 10 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

Clinical relevance of genetic testing is increasing in autism spectrum disorder (ASD). Information about genetic risk may contribute to improved diagnostics, treatment and family planning, but may also be perceived as a burden. Knowledge about the families' preferences with regard to genetic risk information is important for both health care professionals and policy makers. We investigated attitudes towards sharing information about genetic risk of ASD and knowledge about future health among parent members of the Norwegian Autism Association (N = 1455) using a questionnaire, and the relationships with parent and child characteristics, such as age, gender and ASD severity. Most preferred autonomy in deciding whom to inform about genetic risk of ASD (74.4%) and a minority supported extensive intra-familial disclosure of the genetic risk (41.1%). The majority agreed that it is an obligation to know as much as possible relevant for future health (58.0%) and only 51.7% agreed to a principle of a 'right not to know'. In regression models, the attitudes were associated with opinions about benefits and harms of genetic testing (e.g., treatment, family planning, understanding of ASD pathology, insurance discrimination and family conflict). In sum, the findings show that most parents want to know as much as possible relevant for their children's future health and keep their autonomy and intra-familial confidentiality about genetic risk information. Nearly half of the parents were not concerned with a "right not to know". These attitudes can inform development of guidelines and bioethics in the age of genomic precision medicine.

Identifiants

pubmed: 34776508
doi: 10.1038/s41431-021-00966-y
pii: 10.1038/s41431-021-00966-y
pmc: PMC9553933
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1138-1146

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Clin Genet. 2017 Dec;92(6):569-578
pubmed: 28170090
Genet Med. 2009 Dec;11(12):880-9
pubmed: 20010365
J Med Ethics. 2004 Oct;30(5):435-9; discussion 439-40
pubmed: 15467071
Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):375-84
pubmed: 18023043
Hastings Cent Rep. 2019 May;49 Suppl 1:S88-S96
pubmed: 31268566
Bioethics. 2001 Feb;15(1):26-49
pubmed: 11699548
Eur J Health Law. 1999 Jun;6(2):119-32
pubmed: 11657815
Psychiatr Genet. 2016 Apr;26(2):74-80
pubmed: 26867185
J Bioeth Inq. 2020 Sep;17(3):325-335
pubmed: 32557217
J Spec Pediatr Nurs. 2009 Oct;14(4):284-94
pubmed: 19796327
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15161-5
pubmed: 25288738
Philos Trans R Soc Lond B Biol Sci. 2009 May 27;364(1522):1369-75
pubmed: 19528019
J Med Ethics. 2011 Nov;37(11):673-6
pubmed: 21659442
Mol Autism. 2017 Mar 17;8:13
pubmed: 28331572
Health Policy. 2021 Jul;125(7):877-887
pubmed: 33962789
Nat Genet. 2019 Mar;51(3):431-444
pubmed: 30804558
Autism Adulthood. 2019 Jun 01;1(2):124-133
pubmed: 31058260
J Genet Couns. 2009 Oct;18(5):507-19
pubmed: 19488842
J Community Genet. 2020 Oct;11(4):461-473
pubmed: 32248430
J Autism Dev Disord. 2016 Jun;46(6):2000-2016
pubmed: 26873143
Philos Ethics Humanit Med. 2019 Feb 27;14(1):4
pubmed: 30813945
Camb Q Healthc Ethics. 2012 Oct;21(4):457-65
pubmed: 22828040
Issues Ment Health Nurs. 2010 Oct;31(10):631-45
pubmed: 20854036
Nat Rev Dis Primers. 2020 Jan 16;6(1):5
pubmed: 31949163
Hastings Cent Rep. 2019 May;49 Suppl 1:S2-S9
pubmed: 31268574
Int J Mol Sci. 2016 Sep 19;17(9):
pubmed: 27657040
Am J Med Genet B Neuropsychiatr Genet. 2019 Dec;180(8):555-565
pubmed: 30912305
Psychol Med. 2015 Feb;45(3):601-13
pubmed: 25108395
JAMA. 2017 Sep 26;318(12):1182-1184
pubmed: 28973605
Clin Pract Epidemiol Ment Health. 2018 Jul 31;14:143-176
pubmed: 30158998
Psychol Health. 2011 Sep;26(9):1143-55
pubmed: 21347976
Am J Med Genet B Neuropsychiatr Genet. 2020 Oct;183(7):423-432
pubmed: 32812348
Genet Med. 2013 Apr;15(4):274-81
pubmed: 23288207
J Autism Dev Disord. 2021 Dec;51(12):4321-4332
pubmed: 32940822
Curr Psychiatry Rep. 2013 Jan;15(1):334
pubmed: 23250815
Int J Mol Sci. 2017 May 18;18(5):
pubmed: 28524073
Eur J Med Genet. 2016 Sep;59(9):452-8
pubmed: 27544064
Mol Psychiatry. 2022 Jan;27(1):710-730
pubmed: 34002022
Eur J Cancer. 2012 Nov;48(16):3052-62
pubmed: 22726816
Stat Med. 1991 May;10(5):711-5
pubmed: 2068423

Auteurs

Jarle Johannessen (J)

K. G. Jebsen Centre for Neurodevelopmental Disorders, Oslo, Norway. t.j.johannessen@medisin.uio.no.
NevSom, Department of Rare Disorders, Oslo University Hospital, Oslo, Norway. t.j.johannessen@medisin.uio.no.

Terje Nærland (T)

K. G. Jebsen Centre for Neurodevelopmental Disorders, Oslo, Norway.
NevSom, Department of Rare Disorders, Oslo University Hospital, Oslo, Norway.

Sigrun Hope (S)

K. G. Jebsen Centre for Neurodevelopmental Disorders, Oslo, Norway.
NevSom, Department of Rare Disorders, Oslo University Hospital, Oslo, Norway.

Tonje Torske (T)

Division of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway.

Anett Kaale (A)

NevSom, Department of Rare Disorders, Oslo University Hospital, Oslo, Norway.
Department of Special Needs Education, University of Oslo, Oslo, Norway.

Katrine V Wirgenes (KV)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Eva Malt (E)

Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway.
Department of Adult Habilitation, Akershus University Hospital, Nordbyhagen, Norway.

Srdjan Djurovic (S)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.

Marcella Rietschel (M)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Faculty of Medicine Mannheim, University of Heidelberg, Heidelberg, Germany.

Ole A Andreassen (OA)

K. G. Jebsen Centre for Neurodevelopmental Disorders, Oslo, Norway.
NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH